Immune cell senescence drives responsiveness to immunotherapy in melanoma

Abstract Background Immunotherapy has significantly improved cancer treatment. However, it is not effective in all cancer patients, rendering the need to further delineate the differences among responders and non-responders at the molecular and cellular level. Unresponsiveness to immunotherapy has b...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Pavlos Pantelis, Dimitrios Christos Tremoulis, Konstantinos Evangelou, Panagiotis Bakouros, Sophia Magkouta, Orestis A. Ntintas, Dimitris Veroutis, Giorgos Theocharous, Ioannis V. Kostopoulos, Dimitris-Foivos Thanos, Eftychia Chatziioannou, Ioanna A. Anastasiou, Nefeli Lagopati, Dimitrios Valakos, Dimitrios Skaltsas, Oltin Tiberiu Pop, Marie Therese Abdou, Sarantis Gagos, Dimitris Kletsas, Dimitris Thanos, Alexandros J. Stratigos, Martin Röcken, Lukas Flatz, George P. Chrousos, Dimitrios Vlachakis, Ourania E. Tsitsilonis, Russell Petty, Timokratis Karamitros, Vassilis G. Gorgoulis
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2025-12-01
Σειρά:	Molecular Cancer
Θέματα:	Immunotherapy Immune cell senescence Responders Non-responders Melanoma SeneVick
Διαθέσιμο Online:	https://doi.org/10.1186/s12943-025-02517-1
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!